Saghafi et al. [9] found significant differences in MAP during and after CPR, renal failure–free days, coagulation failure–free days, and insulin requirement but not in ventilator–free days between patients with IHCA receiving VSE and those receiving epinephrine–placebo. This evidence concerns the gene INS and acute kidney injury.